Literature DB >> 83714

Dissociation of HLA-D and HLA-DR using primed LD typing.

R J Hartzman, F Pappas, P J Romano, A H Johnson, F E Ward, D B Amos.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 83714

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Restimulation properties of human alloreactive cloned T-cell lines. Dissection of HLA-D-region alleles in population studies and in family segregation analysis.

Authors:  G Pawelec; P Wernet
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

2.  Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.

Authors:  A Zeevi; C Scheffel; K Annen; G Bass; M Marrari; R J Duquesnoy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

3.  Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.

Authors:  D D Eckels; R J Hartzman
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants.

Authors:  A Zeevi; C Scheffel; K Annen; R J Duquesnoy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones.

Authors:  A Zeevi; K Annen; C Scheffel; R J Duquesnoy
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  The HLA-A:HLA-B crossovers and their contribution in analysing possible haplotype-specific recombination rates.

Authors:  K Bender
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

7.  Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.

Authors:  S Shaw; A H Johnson; G M Shearer
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.